Literature DB >> 12695729

Valvular and perivalvular abnormalities in end-stage renal disease.

Ernesto Umana1, Waqas Ahmed, Martin A Alpert.   

Abstract

Valvular and perivalvular involvement in end-stage renal disease (ESRD) is most commonly manifested as mitral annular calcification and aortic valve calcification. Both mitral and aortic valve calcification (MAC) occur more frequently and at younger age in those with ESRD than in those with normal renal function. Aortic valve calcification progresses to aortic stenosis more commonly and at a more accelerated rate than in the general population. Altered calcium and phosphate metabolism are thought to predispose to these valvular and perivalvular abnormalities. No treatment is necessary for MAC unless severe mitral regurgitation or stenosis occur (both are rare). Mitral valve repair or replacement and aortic valve replacement are indicated for severe symptomatic valve stenosis or regurgitation, albeit at a higher risk than in those with normal renal function. Infective endocarditis may complicate MAC or aortic stenosis in patients with ESRD and is associated with a high mortality rate in such patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695729     DOI: 10.1097/00000441-200304000-00010

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  22 in total

Review 1.  Screening for cardiovascular disease before kidney transplantation.

Authors:  Sneha Palepu; G V Ramesh Prasad
Journal:  World J Transplant       Date:  2015-12-24

Review 2.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

3.  A case of histopathologically confirmed infective endocarditis with no vegetations observed during preoperative diagnosis.

Authors:  Takaya Sasaki; Shiko Gen; Kazuhiro Takahashi; Kanako Nobe; Naofumi Ikeda
Journal:  CEN Case Rep       Date:  2015-12-09

Review 4.  Mineral metabolism and cardiovascular disease in CKD.

Authors:  Hideki Fujii; Nobuhiko Joki
Journal:  Clin Exp Nephrol       Date:  2017-01-06       Impact factor: 2.801

5.  Prosthesis selection for aortic valve replacement in patients on hemodialysis.

Authors:  Daijiro Hori; Sho Kusadokoro; Yuichiro Kitada; Naoyuki Kimura; Harunobu Matsumoto; Koichi Yuri; Atsushi Yamaguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-07-06

Review 6.  Direct effects of phosphate on vascular cell function.

Authors:  Wei Ling Lau; Ashwini Pai; Sharon M Moe; Cecilia M Giachelli
Journal:  Adv Chronic Kidney Dis       Date:  2011-03       Impact factor: 3.620

7.  Relationship of bone mineral density with valvular and annular calcification in community-dwelling older people: The Cardiovascular Health Study.

Authors:  Daniele Massera; Shuo Xu; Traci M Bartz; Anna E Bortnick; Joachim H Ix; Michel Chonchol; David S Owens; Eddy Barasch; Julius M Gardin; John S Gottdiener; John R Robbins; David S Siscovick; Jorge R Kizer
Journal:  Arch Osteoporos       Date:  2017-05-30       Impact factor: 2.617

8.  Valvular calcification and risk of peripheral artery disease: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Parveen K Garg; Petra Buzkova; Zahra Meyghani; Matthew J Budoff; Joao Lima; Michael Criqui; Mary Cushman; Matthew Allison
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-10-01       Impact factor: 6.875

9.  A 20-year multicenter analysis of dialysis-dependent patients who had aortic or mitral valve replacement: Implications for valve selection.

Authors:  Joshua L Manghelli; Daniel I Carter; Ali J Khiabani; Jason M Gauthier; Marc R Moon; Nabil A Munfakh; Ralph J Damiano; Joel S Corvera; Spencer J Melby
Journal:  J Thorac Cardiovasc Surg       Date:  2018-12-13       Impact factor: 5.209

10.  Risk of Infective Endocarditis in Patients with End Stage Renal Disease.

Authors:  Mavish S Chaudry; Nicholas Carlson; Gunnar H Gislason; Anne-Lise Kamper; Marianne Rix; Vance G Fowler; Christian Torp-Pedersen; Niels E Bruun
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.